Selection of breast cancer patients for an aromatase inhibitor after radiation and tamoxifen

被引：0
|
作者：
Freedman, GM [1 ]
Anderson, P [1 ]
Li, T [1 ]
Ross, E [1 ]
Swaby, R [1 ]
Goldstein, L [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.413
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2019
引用
收藏
页码：S242 / S242
页数：1
相关论文
共 50 条
  • [1] Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen
    Freedman, Gary M.
    Anderson, Penny
    Li, Tianyu
    Ross, Eric
    Swaby, Ramona
    Goldstein, Lori
    CANCER, 2006, 107 (11) : 2552 - 2558
  • [2] Changes in endometrial thickness after conversion from tamoxifen to aromatase inhibitor in postmenopausal breast cancer patients
    Hwang, Kyuri
    Hwang, Ki Tae
    Kim, Yong Jin
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (12): : 1452 - 1452
  • [3] Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen
    Booth, Christopher M.
    Pater, Joseph L.
    Goss, Paul E.
    CANCER, 2007, 109 (09) : 1927 - 1928
  • [4] Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer
    Eggemann, Holm
    Altmann, Udo
    Costa, Serban-Dan
    Ignatov, Atanas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (02) : 337 - 341
  • [5] Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer
    Holm Eggemann
    Udo Altmann
    Serban-Dan Costa
    Atanas Ignatov
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 337 - 341
  • [6] Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: Why, who and how long?
    Kaufmann, Manfred
    Rody, Achim
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 126 (02) : 146 - 154
  • [7] Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen - Author reply
    Freedman, Gary M.
    CANCER, 2007, 109 (09) : 1928 - 1928
  • [8] Compliance and persistence of tamoxifen and aromatase inhibitors in breast cancer patients
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 96 - 97
  • [9] Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors
    Xu, Xiaoqing
    Chlebowski, Rowan T.
    Shi, Jiaxiao
    Barac, Ana
    Haque, Reina
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (03) : 785 - 794
  • [10] Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors
    Xiaoqing Xu
    Rowan T. Chlebowski
    Jiaxiao Shi
    Ana Barac
    Reina Haque
    Breast Cancer Research and Treatment, 2019, 174 : 785 - 794
12345